June 18th 2024
Yimmugo, which was introduced in Europe at the end of 2022, could be on the market in the US within months.
FDA Warns of Amino Acid Shortage Due to Hurricane Maria
December 1st 2017In a recently released statement, FDA Commissioner Scott Gottlieb warned of an amino acids supply shortage and gave an update on a saline supply shortage, both due to the impact of hurricanes on Puerto Rican manufacturing facilities.
Capsugel Expands Clinical Trial Services at UK Manufacturing Facility
November 2nd 2017Capsugel announced on Oct. 31, 2017 that it expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products using liquid-filled hard capsule technology, at its Edinburgh facility in Scotland.
Lilly to Invest $72 Million for Insulin Manufacturing Upgrade
October 23rd 2017The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.